Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome

• Published in: Cytokine (Philadelphia, Pa.) Pa.), 2020-04, Vol.128, p.155002-155002, Article 155002
• Main Authors: Pishgahi, Alireza, Abolhasan, Rozita, Danaii, Shahla, Amanifar, Bahareh, Soltani-Zangbar, Mohammad Sadegh, Zamani, Majid, Kamrani, Amin, Ghorbani, Farzaneh, Mehdizadeh, Amir, Kafil, Hossein Samadi, Jadidi-Niaragh, Farhad, Yousefi, Bahman, Hajialiloo, Mehrzad, Yousefi, Mehdi
• Format: Article
• Language: English
• Subjects: Ankylosing Spondylitis; Immunological factors; Metabolic syndrome; Oxidative stress
• ISSN: 1043-4666; 1096-0023
• DOI: 10.1016/j.cyto.2020.155002

•AS is an inflammatory and autoimmune disorder with unknown etiology.•MetS induces reactive oxygen species production in inflammatory conditions.•Oxidative stress can affect the pathophysiology of Ankylosing Spondylitis.•Pathogenesis of AS probably mediated by inflammation in AS patients with MetS. Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine and sacroiliac joints with unidentified etiology closely associated with metabolic syndrome (MetS). Recent studies have reported that immunological and oxidative stress factors are implicated in AS pathogenesis. The aim of this study was to investigate the oxidative and immunological factors in AS patients with or without MetS compare to control group. Real-Time PCR measured expression level of cytokines, transcription factors and related miRNAs. In addition, Th17 and Treg frequencies and cytokines secretion were evaluated by flowcytometry and ELISA methods, respectively. The oxidative stress biomarkers were also assessed with biochemical methods. In AS patients with MetS, higher Th17 and lower Treg frequency were observed. Increased levels of NF-kB and AP-1 mRNA expression were seen in AS patients with MetS (p = 0.0263 and p = 0.0104, respectively). MiR-146a and miR-223 were significantly decreased (p = 0.0005, p = 0.0161, respectively) and increase in miR-21 (p = 0.0002) was observed in AS patients with MetS compared to AS patients without MetS. Additionally, the secretion of TNF-α (p = 0.0167), IL-1β (p = 0.303), CCL2 (p = 0.0254), CCL3 (p = 0.0119), CXCL8 (p = 0.0364), adiponectin (p = 0.0183) and the levels of SOD (p = 0.0421), NO (p = 0.0451) and CAT (p = 0.0128) were increased in AS patients with MetS. We were not observed significant differences in TOS and GPX levels between studied groups. The higher levels of oxidative stress and immunological inflammatory markers in AS patients with MetS provide further evidences on the oxidative stress and immunological relationship in these patients.